These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19858930)

  • 1. Impact of HIV prevention programs on drug users in Malaysia.
    Kamarulzaman A
    J Acquir Immune Defic Syndr; 2009 Nov; 52 Suppl 1():S17-9. PubMed ID: 19858930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaysia and harm reduction: the challenges and responses.
    Reid G; Kamarulzaman A; Sran SK
    Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing the spread of HIV among Australian injecting drug users.
    Wodak A
    Forensic Sci Int; 1993 Nov; 62(1-2):83-7. PubMed ID: 8300039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection among injecting drug users in Asia: an evolving public health crisis.
    Wodak A; Crofts N; Fisher R
    AIDS Care; 1993; 5(3):313-20. PubMed ID: 8218466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives.
    Inchaurraga S
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S366-71. PubMed ID: 14648449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV testing for HIV prevention: a comparative analysis of policies in Britain, Hungary and Sweden.
    Danziger R
    AIDS Care; 1998 Oct; 10(5):563-70. PubMed ID: 9828953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transition to harm reduction: understanding the role of non-governmental organisations in Malaysia.
    Narayanan S; Vicknasingam B; Robson NM
    Int J Drug Policy; 2011 Jul; 22(4):311-7. PubMed ID: 21300533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.
    Hilton BA; Thompson R; Moore-Dempsey L; Janzen RG
    J Adv Nurs; 2001 Feb; 33(3):357-70. PubMed ID: 11251723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives.
    Rhodes T; Platt L; Sarang A; Vlasov A; Mikhailova L; Monaghan G
    J Urban Health; 2006 Sep; 83(5):911-25. PubMed ID: 16855880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection among injecting drug users in north-east Malaysia, 1992.
    Singh S; Crofts N
    AIDS Care; 1993; 5(3):273-81. PubMed ID: 8218462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.
    Degenhardt L; Mathers BM; Wirtz AL; Wolfe D; Kamarulzaman A; Carrieri MP; Strathdee SA; Malinowska-Sempruch K; Kazatchkine M; Beyrer C
    Int J Drug Policy; 2014 Jan; 25(1):53-60. PubMed ID: 24113623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of hepatitis C and human immunodeficiency virus infections among injecting drug users in Hungary--what's next?].
    Gyarmathy VA; Rácz J
    Orv Hetil; 2010 Mar; 151(10):365-71. PubMed ID: 20178967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling HIV among injecting drug users: the current status of harm reduction.
    Wodak A
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):77-80. PubMed ID: 17375432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis.
    Ahmed T; Long TN; Huong PT; Stewart DE
    BMC Public Health; 2015 Jan; 15():32. PubMed ID: 25631330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV, injecting drug use and harm reduction: a public health response.
    Ball AL
    Addiction; 2007 May; 102(5):684-90. PubMed ID: 17506148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of harm reduction in preventing HIV among injecting drug users.
    Wodak A; Maher L
    N S W Public Health Bull; 2010; 21(3-4):69-73. PubMed ID: 20513304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.